Skip to main content

and
  1. Article

    Open Access

    Prevalence of pathogenic germline variants in the circulating tumor DNA testing

    Somatic and germline variants are not distinguishable by circulating tumor DNA (ctDNA) testing without analyzing non-tumor samples. Although confirmatory germline testing is clinically relevant, the criteria f...

    Yoshihiro Yamamoto, Keita Fukuyama in International Journal of Clinical Oncology (2022)

  2. No Access

    Article

    Germline sequencing for presumed germline pathogenic variants via tumor-only comprehensive genomic profiling

    The European Society for Medical Oncology Precision Medicine Working Group (ESMO-PMWG) published recommendations regarding confirmatory germline testing for presumed germline pathogenic variants (PGPVs) in tum...

    Tomohiro Kondo, Yoshihiro Yamamoto in International Journal of Clinical Oncology (2022)